Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to -$239000.0.

  • Cellebrite DI's Gains from Investment Securities fell 10628.78% to -$239000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $7.0 million, marking a year-over-year decrease of 9281.26%. This contributed to the annual value of $134000.0 for FY2025, which is 9987.89% down from last year.
  • Cellebrite DI's Gains from Investment Securities amounted to -$239000.0 in Q4 2025, which was down 10628.78% from $4.7 million recorded in Q3 2025.
  • Over the past 5 years, Cellebrite DI's Gains from Investment Securities peaked at $71.3 million during Q3 2024, and registered a low of -$17.1 million during Q1 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.3 million (2025), whereas its average is $4.4 million.
  • As far as peak fluctuations go, Cellebrite DI's Gains from Investment Securities plummeted by 108201.39% in 2021, and later surged by 495741.94% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Gains from Investment Securities stood at -$15.5 million in 2021, then skyrocketed by 102.42% to $375000.0 in 2022, then soared by 2509.33% to $9.8 million in 2023, then tumbled by 61.15% to $3.8 million in 2024, then tumbled by 106.29% to -$239000.0 in 2025.
  • Its last three reported values are -$239000.0 in Q4 2025, $4.7 million for Q3 2025, and $1.7 million during Q2 2025.